On the maximum value of the first coefficients of Kazhdan-Lusztig polynomials for symmetric
スポンサーリンク
概要
- 論文の詳細を見る
In this article, we show that max$\{c^-(w);w \in \frak S_n\} = [n^2/4]$, where $c^-(w)$ is the number of elements covered by $w \in \frak S_n$ in the Bruhat order. Using this result, we can see that the maximum value of the first coefficients of Kazhdan-Lusztig polynomials for $\frak S_n$ equals $[n^2/4]- n + 1$.
- 東京大学の論文
著者
-
TAGAWA Hiroyuki
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
-
Tagawa Hiroyuki
Department Of Hematology Nephrology And Rheumatology Akita University Graduate School Of Medicine
-
Tagawa Hiroyuki
Department Of Mathematical Sciences University Of Tokyo
-
Tagawa Hiroyuki
Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital
関連論文
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- A case of intravascular large B-cell lymphoma of the cutaneous variant : the first case in Asia
- Kidney-limited intravascular large B cell lymphoma : a distinct variant of IVLBCL?
- Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c^+ dendritic cells derived from CD34^+ cells exposed to TNF-α
- A multivariable quantum determinant over a commutative ring(Combinatorial Aspects in Representation Theory and Geometry)
- On the maximum value of the first coefficients of Kazhdan-Lusztig polynomials for symmetric
- Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells
- Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma
- Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia
- Photochemical reaction of benzophenones with allylic silanes.